/Richard Christopher/ - 02 Dec 2024 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role: Chief Executive Officer
Signature: /Richard Christopher/
Issuer symbol: LEXX
Transactions as of: 02 Dec 2024
Net transactions value: +$118,392
Form type: 4
Filing time: 03 Dec 2024, 14:03:28 UTC
Previous filing: 05 Sep 2024
Next filing: 16 May 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LEXX	common shares	Purchase	$51,217	+22,828		$2.24	22,828	02 Dec 2024	Direct
transaction	LEXX	common shares	Purchase	$67,175	+27,172	+119%	$2.47	50,000	03 Dec 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	LEXX	Stock Options						200,000	02 Dec 2024	Common Shares	200,000	$3.92	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Options are vested as to 50,000 on February 28, 2025 with 6,818 being vested monthly thereafter until November 30, 2026 whereby the balance of 6,822 options will be vested on December 31, 2026